Health Belief Model-based Education and Motivational Interview Regarding the HPV Vaccination Decision

This research is a single-blind, randomized, parallel-controlled experimental study designed to determine the effect of Health Belief Model (SIM)-based motivational interviews given to mothers of high school students on mothers' knowledge, beliefs and attitudes towards HPV vaccine. . The hypotheses of the research; The experimental group that received training and motivational interviews within the framework of SIM had higher knowledge and perception of HPV infection and vaccination in the posttest than the control group that did not receive any application.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

HPV VACCINATION Communicable Diseases DNA Virus Infections Disease Attributes Genital Diseases Infections Papillomavirus Infections Pathologic Processes Pathological Conditions, Signs and Symptoms Sexually Transmitted Diseases Sexually Transmitted Diseases, Viral Tumor Virus Infections Urogenital Diseases Virus Diseases

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

Mersin University

Mersin, 33343, Turkey (Türkiye)

About this study

Methods: In order to determine the sample size of the study, it was planned to work with a total of 54 patients, at least 27 patients in each group, in the power analysis performed by taking the reference information of the statistician and previous studies, and the study was completed with a total of 63 people (31 in the experimental group, 32 in the control group). The Health Belief Model-based motivational interview will be conducted over the phone and will last 15-20 minutes. One week after each motivational interview, a questionnaire and scale form will be applied to the mothers. After the third meeting, the study will be completed by applying the questionnaire and scale forms. Finally, the questionnaire for measurement will be filled and the research will be completed.

The control group will be subjected to routine processing without any intervention. Questionnaire forms were applied to the control group simultaneously with the experimental group. At the end of the study, a single-session motivational interview will be held by the researcher, since the patients in the control group have equal ethical rights. The primary result expected from the study is that mothers' perceptions of the benefit, sensitivity and severity of HPV vaccine increase, and their perception of barriers decreases. The secondary result expected from the study is the increase in mothers' knowledge about HPV infection and vaccination. The tertiary expected outcome of the study is that the mother sees her daughter at risk of HPV infection and decides to have her daughter vaccinated against HPV.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Those who live in Mersin and are female students in two high schools determined between 15.03.2020 and 15.06.2021.,
Daughter not vaccinated against HPV,
Undecided about getting her daughter vaccinated against HPV,
Who doesn't plan to have their daughter vaccinated against HPV,
who agreed to participate in the research,
Literate,
Can speak Turkish,,
Having no hearing or sight impairment that will prevent communication,,
Able to talk on the phone and use whatsapp,,
Participants without a diagnosed psychiatric problem were included in the study..

Exclusion criteria

Having her daughter vaccinated against HPV,
Thinking of getting her daughter vaccinated against HPV,
Who refused to participate in the research,
Illiterate,
Don't speak Turkish,
People with hearing or sight impairments that may interfere with communication,
Can't talk on the phone and can't use whatsapp,
Participants with diagnosed psychiatric problems were excluded from the study.

Treatment and study plan

education and motivational interview

Other

The control group will remain subject to the routine process without any intervention.

Primary outcomes

Primary Outcome Measures: Health Belief was assessed with the Health Belief Model Scale for Human Papilloma Virus Infection and Vaccination

Time frame: Change from before implementation, 1th week, 2th week and 3th week of practice

It was developed by Kim (2012) to measure health beliefs towards the HPV vaccine. The scale consists of 4 subscales: benefits (1-3 items), perceived disability (10-14 items), sensitivity (4-5 items), severity (6-9 items) and a total of 14 items. The scale items are interpreted as four-point likert type, with 1 as "not at all", 2 as "a little", 3 as "quite a lot", and 4 as "a lot". The total score range of the scale is 14-56. As the scale score increases, the perception also increases.
HPV information assessed with HPV information scale

Time frame: Change from before implementation, Change from before implementation, 1th week, 2th week and 3th week of practice

The HPV knowledge scale was developed by Waller et al (2013) to measure the knowledge levels of individuals about HPV, HPV vaccine and screening tests. In the scale with a total of 33 items; It consists of four sub-dimensions: general HPV information (1-16 items), HPV screening test information (17-22 items), general HPV vaccine information (23-27 items) and information about the current HPV vaccination program (28-33 items). Participants are expected to mark each item of the scale as "Yes", "No" and "I don't know". In the evaluation phase, each correct answer is scored with=1, while incorrect answers and I don't know are scored with=0. In order to avoid bias in the answers, the correct and incorrect answers were mixed as in the original scale. The total score to be obtained from the scale is between 0-33, and a high score indicates a high level of knowledge about HPV, HPV screening tests and HPV vaccine.

Sponsors and collaborators

Lead sponsor

Yasemin ATEŞEYAN

Other

Registry information

Official study title

The Effect of Health belıef Model Based educatıon and motıvatıonal intervıewıng on Mothers' Knowledge, belıef and attıtudes Towards Hpv vaccıne

Important dates

Study start: 2020
Primary completion: 2021
Study completion: 2021
First posted: Aug 5, 2021
Registry last updated: Aug 5, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed